A list of requirements for submissions is given below
Editorial policy and general information
Research manuscripts are submitted online through here. Associate Editor and at least two reviewers will review submitted manuscripts. The Editor-in-Chief is ultimately responsible for all decisions. In general, articles submitted to IJAC are expected to be original work that has not been previously published or under consideration by another publication.
We accept original and review articles, short communications, case reports and letters to the editor.
Research manuscripts in the following areas will be reviewed:
• Theoretical foundations, professional opinion of acute care
• Innovations and clinical approaches in caring and curing
• Comparative study of caring and curing models
• New strategies in continuing professional development, teaching and learning
• Ethical issues
• Management, quality assurance, validation and evaluation methods
• Information and communication technology
• Software used in acute care settings
• Health policy and continual quality improvement
We may also consider other topics.
Manuscripts are evaluated on the basis that they present new insight into the investigated topic and are likely to contribute to research progress or a change in clinical practice. It is understood that all authors listed on a manuscript meet the appropriate criteria for authorship. The signature of the corresponding author on the letter of submissionin accordance with ICMJE guidance on authorship signifies that these conditions have been fulfilled. Received manuscripts will initially be examined by the IJAC editorial office and those deemed to have insufficient grounds for publication may be rejected without external evaluation. Manuscripts not prepared in the advised style described below will be sent back to authors for correction. The authors will be notified with a reference number once the manuscript has been assigned to an Editor. The assigned manuscripts will be sent to 2-4 independent experts for scientific evaluation. The evaluation process commonly takes an average of 1-2 months.
Authors wishing to include figures, tables, or text that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any received material lacking such evidence will be assumed to originate from the authors.
Every effort is made by the publisher and editorial board to ensure that no inaccurate or misleading data or statements appear in the journal. However, they wish to make it clear that the data and opinions appearing in the articles herein are the responsibility of the authors concerned. Accordingly, the publisher and the editorial board accept no liability whatsoever for the consequences of any inaccurate or misleading data or statements, intentional or not.
IJAC seeks to publish experimental and theoretical research results of outstanding significance in the form of original articles, short communications, reviews, case reports, or letters to the editor.
1. Original articles: Articles which represent in-depth research in various scientific disciplines.
2. Short communications: Should be complete manuscripts of significant importance. However, their length and/or depth do not justify a full-length paper. The total number of figures and tables should not exceed four. The number of words should beless than 3,000.
3. Systematic reviews and meta-anlayses: Should normally comprise less than 10,000 words; contain unstructured abstract and include up-to-date references. Special attention will be paid to the educational value of review papers.
4. Mini reviews: These are reviews of important and recent topics that are presented in a concise and well-focused manner. The number of words is limited to 5,000.
5. Case reports: A detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient (i.e., clinically important information on common and rare conditions).
6. Letter to the editor for comments on recently published articles.
7. Special reports: Papers may be accepted on the basis that they provide a systematic, critical and up-to-date overview of literature pertaining to research or clinical topics.
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Studies involving patients or volunteers require Ethics Committee and/or Independent Review Board (IRB) approval, and, where relevant, the patients' written informed consent, which should be documented in the Methods section of the paper. If such a study was not approved by the appropriate Ethics Committee or IRB, a statement as to why it was exempted should be included. The Editors reserve the right to refuse publications where the required ethical approval/patient consent is lacking.
Human and animal rights
The IJAC editors endorse the principles embodied in the revised Declaration of Helsinki (2008) (59th WMA General Assembly, Seoul, Republic of Korea, October 2008) and expect that all investigations involving humans would have been performed in accordance with these principles. For animal experimentation, it is expected that investigators have abided by the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences Adhoc Committee on Animal Research. All human and animal studies must have been approved by the investigator's Institutional review board.
For studies involving human subjects, download the letter from here
For studies involving animals (fisheries), download the letter from here
For studies that do not involve human or animal subjects (Basic sciences), download the letter from here
Conflict of Interest (mandatory)
A conflict of interest may exist when an author or the author's institution has financial or other affiliations with people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of any relationships that could be viewed as potential conflicts of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. This declaration (with the heading "Conflict of interests") must be included on the title page. Additional information regarding conflicts of interest can be found here.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis or as an electronic preprint, see 'Multiple, redundant or concurrent publication' section of our ethics policy for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Changes to authorship
Request to changes in authorship is not allowed once the paper is accepted. In case any such changes needs to be made then the author would have to withdraw his paper and resubmit it with the new author details in the Editorial System.
Upon acceptance of an article, authors will be asked to complete a 'Copyright Transfer Agreement'. Acceptance of the agreement will ensure the widest possible dissemination of information. Subscribers may reproduce tables of content or prepare lists of articles including abstracts for internal circulation within their institutions.
Role of the funding source
Please list the source(s) of funding for the study, for each author, and for the manuscript preparation in the acknowledgements section. List all contributors who do not meet the criteria for authorship, such as technical assistants, writing assistants or head of department who provided only general support. Financial and other material support should be disclosed and acknowledged.
As the Lorestan University of Medical Sciences has supported all of the publishing costs of this journal, every research manuscript accepting in this journal will be published open access.
This means that no charges will be imposed for article processing (Acceptance Fee) and the article is freely and universally accessible via the internet in perpetuity, in an easily readable format immediately after publication.
All articles will be published under the following license: Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
Creative Commons license
Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) which allows users to copy and distribute the Article, provided this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way, and provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, and that the licensor is not represented as endorsing the use made of the work. The full details of the license are available here.
Note: If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication by contacting Customer Support.
Compliance with funder mandated open access policies
An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here
FAQ for open access can be found here
All articles published open access will be immediately and permanently free for everyone to read, download, copy and distribute.
Permitted reuse is defined by the following user license:
For open access publishing, this journal uses a copyright transfer agreement. Authors will transfer copyright to the journal, but will have the right to share their article in the same ways permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
Manuscripts must be written in English in a clear and concise manner. Any author who is not fluent in idiomatic English is urged to seek assistance with manuscript preparation prior to submission. Reviewers are not expected to correct grammatical errors and any deficiency in this area may detract from the scientific content of the paper and result in acceptance delays or rejection
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your manuscript files to a single PDF file used in the peer-review process. Editable files are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail.
Submit your article
Please submit your article via hear
You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact email@example.com, Phone: 276 944-6494.
The original manuscript should be formatted with double line spacing using Times New Roman fonts (12 pt). The text must be in a single-column format with justified margins. Use bold face, italics, subscripts, and superscripts where appropriate. To avoid unnecessary errors, the authors are strongly advised to use the "spell-check" and "grammar-check" functions of their word processing software. Use continuous line numbering throughout the text and all manuscript pages must be numbered at the bottom right corner of each page.
IJAC requires "people-first" language. Subjects/patients should not be labelled by a disability, medical condition, diagnosis, etc. Terms such as "total knee patients," "diabetics" and so forth are not acceptable. "Patients receiving TKA" or "patients with diabetes" are acceptable phrases. Any terminology that dehumanizes the people described in the manuscript should not be used.
The authors must submit the revised version of their submissions within one month of receiving the editorial decision. Revision does not mean that the manuscript will be accepted for publication, as the amended submissions could be sent out for re-evaluation. In response to reviewers’ comments, the authors must ensure that each comment is followed by their revision and/or response. In instances where an author disagrees with a comment or suggestion of a reviewer, please justify the reason. Any associated changes in the manuscript must be highlighted on the revised form of the manuscript to facilitate the process of re-evaluation.
Resubmission of a rejected manuscript
When resubmitting a manuscript previously rejected by IJAC, the authors are required to upload the decision letter from the Editor requesting submission of the rejected manuscript, the original reviewer comments of the rejected manuscript, the responses to the reviewer comments, and the original manuscript number. The resubmitted manuscript must indicate, in color, where the revisions were made in the paper in response to the reviewer comments
This journal operates a double blind review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final.
All submitted papers are subjected to strict double blind peer reviewing process. The Journal is committed to publishing manuscripts via a rapid, impartial, and rigorous review process. Once accepted, manuscripts are granted free online open-access immediately upon publication, which permits its users to read, download, copy, distribute, print, search, or link to the full texts, thus facilitating access to a broad readership. The journal is published 4 times per year.
Authors are urged to be succinct; long papers with many tables and figures may require reductions prior to being processed or accepted for publication. Although there is not an absolute length restriction for original papers, authors are encouraged to limit the text to 5,000 words (including references) and references up to 40 references.
The manuscript should be compiled in the following order:
1. Title page
2. Abstract, Key words
4. Material and methods
The author(s) should strive to define the significance of the work and the justification for its publication. Introduction providing the rationale for the study, which generally takes the form of identifying the status quo, identifying a conflict, and generating a hypothesis
Material and methods
Methods including number of subjects, rationale for the sample size, how subjects are assigned to groups, research design, methodology, and statistical analysis. Statements regarding protection of subjects should be placed in this section. For statistical analysis, please state the appropriate test(s) in addition to hypothesized p-value or significant level (for example 0.05).
Protection of participants
The name of the Institutional Review Board or Institutional Animal Care and Use Committee that approved the research protocol must be included in the published Methods section of the manuscript. Blind the name of the IRB or IACUC in the submitted version. Affiliations and other masked information will be placed into the manuscript during the layout process.
The study results should be clear and concise. Summary data should be reported as mean (SD) or median (range) as appropriate based on the type of data. Do not use ± within the text or tables .Restrict the use of tables and figures to depict data that is essential to the message and interpretation of the study. Do not duplicate data in both figures and tables. The results should be presented in a logical sequence in the text, tables and illustrations.
This should explore the significance of the results of the work, not repeat them. Include in the discussion the implications of the findings and their limitations, how the findings fit into the context of other relevant work, and directions for future research. Clinical relevance should be the major emphasis of this section.
The main conclusion(s) of the study should be presented in a short conclusion statement that can stand alone and be linked with the goals of the study. State new hypotheses when warranted. Include recommendations when appropriate. Unqualified statements and conclusions not completely supported by the obtained data should be avoided.
Essential title page information
The title page should include the following:
1. Title: The title should be brief, concise, and descriptive. It should not contain any literature references or compound numbers or non-standardized abbreviations.
2. Authors and affiliations: Supply given names, middle initials, and family names for complete identification. Use superscript lowercase letters to indicate different affiliations, which should be as detailed as possible and must include department, faculty/college, University, city with zip code or P.O. Box and country.
3. Corresponding author : Should be indicated with an asterisk, and contact details (Tel., fax, and e-mail address) should be placed in a footnote.
Short running title (running head) with 80 characters as maximum.
The Manuscript text should include the following:
Provide an unstructured abstract of no more than 250 words. The abstract should briefly describe the purpose of the study, how the investigation was performed, the most important results and the principal conclusions that were drawn from the results, respectively. References should be avoided. Non-standard or uncommon abbreviations should be avoided, but if essential, be defined at first mention within the abstract.
Authors are asked to provide (4 to 6) keywords, separated with semicolons. These keywords are used for indexing purposes
Please acknowledge individuals/companies/institutions who have contributed to the study, as well as entities providing financial support. All funding sources supporting the work must be acknowledged on the title page, which is blinded from reviewers.
Nomenclature and Units
All measurements and data should be given in SI units where possible, or in other internationally accepted units in parentheses throughout the text. Figures and Tables should use conventional units, with conversion factors given in legends or footnotes.
The preferred forms for some of the more commonly used abbreviations are mp, bp, °C, K, min, h, mL, &mgr;L, g, mg, &mgr;g, cm, mm, nm, mol, mmol, &mgr;mol, M, mM, &mgr;M, ppm, HPLC, TLC, GC, 1H NMR, GC-MS, HRMS, FABHRMS, UV, IR, EPR, ESR, DNase, ED50, ID50, IC50, LD50, im, ip, iv, mRNA, RNase, rRNA, tRNA, cpm, Ci, dpm, Vmax, Km, k, t1/2.
All non-standard abbreviations should be defined following the first use of the abbreviation.
The number of illustrations should be
There should be maximum of 5 tables, and these should include only essential data. They should be uploaded on separate sheets with their legends.
Text: Indicate references by Arabic numerals in brackets, which run in order of appearance throughout the text (Vancouver style). For instance  or [7-10, 13,15]. The actual authors can be referred to, but the reference number(s) must always be given.
List: Number the references (e.g., 1.) in the list in the order in which they appear in the text. Journal names should be abbreviated according to Index Medicus journal abbreviations.
Examples of references (if 6 or fewer authors, list all; if 7 or more, list first 6 and add "et al."):
- For journal articles
Abd El-Aty AM, Goudah A, Zhou HH. Pharmacokinetics of doxycycline after administration as a single intravenous bolus and intramuscular doses to non-lactating Egyptian goats. Pharmacol Res. 2004; 49(5): 487-91.
Kramarz P, DeStefano F, Gargiullo PM, Chen RT, Lieu TA, Davis RL, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138:306-10.
- For articles in press (online)
Hellems MA, Gurka KK, Hayden GF. A review of The Journal of Pediatrics: The first 75 years. J Pediatr (2008). doi:10.1016/j.jpeds.2008.08.049.
- For Books
Rosenstein BJ, Fosarelli PD. Pediatric pearls: the handbook of practical pediatrics. 3rd ed. St Louis: Mosby; 1997.Virginia Law Foundation. The medical and legal implications of AIDS. Charlottesville (VA): The Foundation; 1987.
- For book chapters
Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill; 2001. p. 3421-52.
- For websites
American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html -219.
For more samples please check here and here.
These items should be uploaded in the following order:
1. Cover letter (mandatory) Please upload the completed customized cover letter, which can be downloaded here.
2. Title page: Because manuscripts undergo a blind review process, all author names, affiliations and any other potentially identifying information are to be placed only on the title page, which will be masked from the reviewers. Mention of authors or their affiliations within the manuscript must be blinded by the author.
3. Main document, which includes the title page, text, references, tables, and figures (mandatory)
4. Conflict of Interest (mandatory)
5. Compliance with Ethics Requirement (mandatory)
6. Graphical abstract (mandatory for review article) A Graphical Abstract is a single, concise, pictorial and visual summary of the main findings of the article. This could either be the concluding figure from the article or a figure that is specially designed for the purpose, which captures the content of the article for readers at a single glance. The Graphical Abstract will be displayed in online contents list and the online article
The following list will be useful during the final checking of an article prior to sending it to the journal for review. Please consult this Guide for Authors for further details of any item. Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
1. E-mail address
2. Phone number(s)
All necessary files have been uploaded, and include:
2. All figure captions
3. All tables (including title, description, footnotes)
1. Manuscript has been 'spell-checked' and 'grammar-checked'
2. References are in the correct format for this journal
3. All references mentioned in the Reference list are cited in the text, and vice versa
4. Permission has been obtained for use of copyrighted material from other sources (including the Web)
Availability of accepted article
This journal makes articles available online as soon as possible after acceptance. This concerns the accepted article (both in HTML and PDF format), which has not yet been copyedited, typeset or proofread. A Digital Object Identifier (DOI) is allocated, thereby making it fully citable and searchable by title, author name(s) and the full text. The article's PDF also carries a disclaimer stating that it is an unedited article. Subsequent production stages will simply replace this version.